Secretome Therapeutics

Developer of cell-based therapies for multiple diseases

placeDallas, Texas, United States calendar_todayFounded 2018 groups8 employees language secretometherapeutics.com

Registered entities

Innovation

1 patent family — focus: Human necessities; filing pace slowing. Cited 148 times.

YearFilings
20221
20231
20251

Social engagement

Social engagement: 2.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include RA Capital Management.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon